Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides selectively lethal to malignant and transformed mammalian cells

Peptides selectively lethal to malignant and transformed mammalian cells

US Patent 7883888 · Granted Feb 8, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Porphene, a heterocyclic analog of graphene, methods of making and using the sam2023
Methods for treating cancer2021
Methods for treating cancer2020
Modified heterocyclase2020
In vitro production of cyclic peptides2019
Methods for treating cancer2019
Peptides for treating cancer2017
Small molecule cancer treatments that cause necrosis in cancer cells but do not 2017
Small molecule cancer treatments that cause necrosis in cancer cells but do not 2017
Phenotypic reversion of pancreatic carcinoma cells2015
Phenotypic reversion of pancreatic carcinoma cells2015
Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rat2014